530 related articles for article (PubMed ID: 23039393)
1. Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?
McNamara RK; Lotrich FE
Expert Rev Neurother; 2012 Sep; 12(9):1143-61. PubMed ID: 23039393
[TBL] [Abstract][Full Text] [Related]
2. Mitigation of Inflammation-Induced Mood Dysregulation by Long-Chain Omega-3 Fatty Acids.
McNamara RK
J Am Coll Nutr; 2015; 34 Suppl 1(0 1):48-55. PubMed ID: 26400435
[TBL] [Abstract][Full Text] [Related]
3. Immune-based strategies for mood disorders: facts and challenges.
Colpo GD; Leboyer M; Dantzer R; Trivedi MH; Teixeira AL
Expert Rev Neurother; 2018 Feb; 18(2):139-152. PubMed ID: 29179585
[TBL] [Abstract][Full Text] [Related]
4. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
5. Inflamed moods: a review of the interactions between inflammation and mood disorders.
Rosenblat JD; Cha DS; Mansur RB; McIntyre RS
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():23-34. PubMed ID: 24468642
[TBL] [Abstract][Full Text] [Related]
6. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of atypical antipsychotics in mood disorders.
Yatham LN
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S9-14. PubMed ID: 12832944
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant drugs and cytokines in mood disorders.
Nishida A; Hisaoka K; Zensho H; Uchitomi Y; Morinobu S; Yamawaki S
Int Immunopharmacol; 2002 Nov; 2(12):1619-26. PubMed ID: 12469936
[TBL] [Abstract][Full Text] [Related]
9. THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS' PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS.
Goldberg JF; Freeman MP; Balon R; Citrome L; Thase ME; Kane JM; Fava M
Depress Anxiety; 2015 Aug; 32(8):605-13. PubMed ID: 26129956
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis.
Husain MI; Strawbridge R; Stokes PR; Young AH
J Psychopharmacol; 2017 Sep; 31(9):1137-1148. PubMed ID: 28858537
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment.
Siegel AN; Rodrigues N; Nasri F; Wilkialis L; Lipsitz O; Lee Y; Gill H; Subramaniapillai M; Phan L; Majeed A; Lui LMW; Rashidian H; Ho R; Toma S; Goldstein BI; Mansur RB; McIntyre RS; Rosenblat JD
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110032. PubMed ID: 32634540
[TBL] [Abstract][Full Text] [Related]
12. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
13. Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience.
Ménard C; Pfau ML; Hodes GE; Russo SJ
Neuropsychopharmacology; 2017 Jan; 42(1):62-80. PubMed ID: 27291462
[TBL] [Abstract][Full Text] [Related]
14. Resolution of inflammation and mood disorders.
Chistyakov DV; Astakhova AA; Sergeeva MG
Exp Mol Pathol; 2018 Oct; 105(2):190-201. PubMed ID: 30098318
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium.
Sakrajda K; Szczepankiewicz A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546417
[TBL] [Abstract][Full Text] [Related]
16. Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole.
Buckley PF
Drugs Today (Barc); 2005 Jan; 41(1):5-11. PubMed ID: 15753965
[TBL] [Abstract][Full Text] [Related]
17. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
Levinson DF; Umapathy C; Musthaq M
Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of mood disorders.
Thase ME; Denko T
Annu Rev Clin Psychol; 2008; 4():53-91. PubMed ID: 18370614
[TBL] [Abstract][Full Text] [Related]
19. A preclinical and clinical rationale for quetiapine in mood syndromes.
McIntyre RS; Soczynska JK; Woldeyohannes HO; Alsuwaidan M; Konarski JZ
Expert Opin Pharmacother; 2007 Jun; 8(9):1211-9. PubMed ID: 17563257
[TBL] [Abstract][Full Text] [Related]
20. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
